LU82013A1 - Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation - Google Patents

Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation Download PDF

Info

Publication number
LU82013A1
LU82013A1 LU82013A LU82013A LU82013A1 LU 82013 A1 LU82013 A1 LU 82013A1 LU 82013 A LU82013 A LU 82013A LU 82013 A LU82013 A LU 82013A LU 82013 A1 LU82013 A1 LU 82013A1
Authority
LU
Luxembourg
Prior art keywords
thiazolidine
carboxylic acid
pharmaceutically acceptable
pharmaceutical composition
acceptable salt
Prior art date
Application number
LU82013A
Other languages
English (en)
French (fr)
Inventor
M Gosalvez
Original Assignee
M Gosalvez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Gosalvez filed Critical M Gosalvez
Publication of LU82013A1 publication Critical patent/LU82013A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
LU82013A 1978-12-21 1979-12-19 Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation LU82013A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/971,729 US4384001A (en) 1978-12-21 1978-12-21 Treatment of tumors with thiazolidine-4-carboxylic acid
US97172978 1978-12-21

Publications (1)

Publication Number Publication Date
LU82013A1 true LU82013A1 (fr) 1981-02-03

Family

ID=25518727

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82013A LU82013A1 (fr) 1978-12-21 1979-12-19 Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation

Country Status (16)

Country Link
US (1) US4384001A (xx)
JP (1) JPS55115822A (xx)
AU (1) AU5390579A (xx)
BE (1) BE880744A (xx)
CA (1) CA1149284A (xx)
DE (1) DE2951050A1 (xx)
DK (1) DK542979A (xx)
ES (1) ES8102108A1 (xx)
FR (1) FR2444459A1 (xx)
GB (1) GB2039736B (xx)
IL (1) IL58948A0 (xx)
IT (1) IT1193348B (xx)
LU (1) LU82013A1 (xx)
NL (1) NL7909199A (xx)
SE (1) SE7910300L (xx)
ZA (1) ZA796918B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
FR2547728B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide d thiazolidine carboxylique
FR2547729B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide dl thiazolidine carboxylique
WO1986003677A1 (en) * 1984-12-18 1986-07-03 David Rubin Anti-tumor compositions containing the reaction product of a cytotoxic aldehyde with penicillamine and method of use thereof
JPH066578B2 (ja) * 1985-12-27 1994-01-26 三共株式会社 チアゾリジン誘導体
JPH01170063U (xx) * 1988-05-11 1989-11-30
JPH0467539U (xx) * 1990-10-18 1992-06-16
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.

Also Published As

Publication number Publication date
GB2039736B (en) 1983-04-13
ZA796918B (en) 1980-11-26
IT1193348B (it) 1988-06-15
DE2951050A1 (de) 1980-07-10
DK542979A (da) 1980-06-22
IL58948A0 (en) 1980-03-31
AU5390579A (en) 1980-06-26
ES487052A0 (es) 1980-12-16
JPS6328045B2 (xx) 1988-06-07
ES8102108A1 (es) 1980-12-16
JPS55115822A (en) 1980-09-06
US4384001A (en) 1983-05-17
FR2444459B1 (xx) 1983-04-01
BE880744A (fr) 1980-06-19
SE7910300L (sv) 1980-06-22
GB2039736A (en) 1980-08-20
NL7909199A (nl) 1980-06-24
IT7928170A0 (it) 1979-12-18
FR2444459A1 (fr) 1980-07-18
CA1149284A (en) 1983-07-05

Similar Documents

Publication Publication Date Title
US20230128449A1 (en) Silicate containing compositions and methods of treatment
LU82013A1 (fr) Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation
JP2004002429A (ja) 組成物およびその治療用途
EP0059148B1 (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux
JP5086331B2 (ja) 細菌性疾患、ウィルス性疾患、真菌症、炎症、及び疼痛の治療用組成物
EP1267881B1 (fr) UTILISATION DE MnTBAP DANS LE TRAITEMENT D'INSUFFISANCES HEPATOCELLULAIRES
FR2536995A1 (fr) Composition pour le traitement de l'arthrite
EP3624822B1 (fr) Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc
EP1061938B1 (en) Oral compositions at low dosage of cytotoxic proteins
EP4045058A1 (fr) Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes
EP1967187B1 (fr) Composition à base de rutine et de L-lysine
EP0152366A2 (fr) Compositions à usage thérapeutique comprenant des composés organo-siliciés
JP5376786B2 (ja) 神経細胞賦活組成物
FR2572284A1 (fr) Nouveau medicament modulateur de l'immunite a base de diethyldithiocarbamate et son procede de preparation
TWI722492B (zh) 含蓮蓬萃取物之組合物及其用於治療頭頸癌症之用途
FR2683455A1 (fr) Composition pour la stimulation de la synthese localisee des tissus conjonctifs.
FR2779063A1 (fr) Compositions a base de pentoxifylline et leur utilisation therapeutique
CA2027593C (fr) Composition a activite anti-agregante plaquettaire utilisable en therapeutique
WO2000024402A1 (fr) Utilisation d'antifongiques dans le traitement des scleroses
EP4065129A1 (fr) Utilisation de composés pour la prévention et/ou le traitement de la spondylarthrite ankylosante et compositions correspondantes
FR2693208A1 (fr) Procédé d'obtention d'une composition enzymatique d'origine végétale ainsi que composition obtenue par la mise en Óoeuvre de ce procédé.
JPS61180722A (ja) ペプチド‐および/またはアミノ酸含有治療薬
FR2857594A1 (fr) Composition pharmaceutique pour l'administration par voie nasale de piribedil
FR2684297A1 (fr) Utilisation d'un acide amine soufre pour la preparation d'un medicament destine au traitement de l'eczema.
JPWO2006132245A1 (ja) 腫瘍増殖抑制剤